HLA expression and tumor-infiltrating immune cells in uveal melanoma

被引:70
作者
deWaardSiebinga, I
Hilders, CGJM
Hansen, BE
vanDelft, JL
Jager, MJ
机构
[1] UNIV LEIDEN HOSP, DEPT PATHOL, 2300 RC LEIDEN, NETHERLANDS
[2] UNIV LEIDEN HOSP, DEPT MED STAT, 2300 RC LEIDEN, NETHERLANDS
关键词
D O I
10.1007/BF00186516
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background: In uveal melano ma, both the amount of tumor-infiltrating cells and the level of expression of HLA antigens are quite variable. We hypothesized that low levels of HLA expression lead to a lack of antigen presentation, which might prevent proper immunologic recognition of the tumor. This lack of recognition might subsequently lead to low levels of tumor-infiltrating cells. Methods: To test this hypothesis, we determined the type and number of tumor-infiltrating cells in tumor sections from 24 uveal melanomas. We applied monoclonal antibodies directed against different types of immune cells and compared the results with the expression of HLA class I and class II antigens on the turner cells. Results: Infiltrating immune cells were observed in all uveal melanomas (although in small amounts), with a predominance of T lymphocytes. Significant positive correlation:, were observed between the number of CD3+ cells (T lymphocytes) and monomorphic HLA class I expression, allele-specific HLA-A2 and Bw4 expression, and HLA class II expression. Furthermore, the number of CD4+ cells (T helper cells, monocytes/macrophages) and of CD11b+ cells (monocytes/macrophages) was significantly correlated with the level of monomorphic HLA class I expression. Conclusion: These data support our hypothesis that low levels of HLA expression (and therefore a lack of presentation of tumor-specific antigens) may lead to a low level of tumor infiltrate.
引用
收藏
页码:34 / 42
页数:9
相关论文
共 43 条
  • [1] PRODUCTION OF MONOCLONAL ANTIBODIES TO GROUP-A ERYTHROCYTES, HLA AND OTHER HUMAN CELL-SURFACE ANTIGENS - NEW TOOLS FOR GENETIC-ANALYSIS
    BARNSTABLE, CJ
    BODMER, WF
    BROWN, G
    GALFRE, G
    MILSTEIN, C
    WILLIAMS, AF
    ZIEGLER, A
    [J]. CELL, 1978, 14 (01) : 9 - 20
  • [2] MONOCLONAL-ANTIBODY TO HLA-A3
    BERGER, AE
    DAVIS, JE
    CRESSWELL, P
    [J]. HYBRIDOMA, 1982, 1 (02): : 87 - 90
  • [3] CHARACTERIZATION OF A MONOCLONAL ANTI-BETA-2-MICROGLOBULIN ANTIBODY AND ITS USE IN THE GENETIC AND BIOCHEMICAL-ANALYSIS OF MAJOR HISTOCOMPATIBILITY ANTIGENS
    BRODSKY, FM
    BODMER, WF
    PARHAM, P
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1979, 9 (07) : 536 - 545
  • [4] CLAASEN HHV, 1992, LAB INVEST, V67, P166
  • [5] DELACRUZ PO, 1990, CANCER-AM CANCER SOC, V65, P112
  • [6] DURIE FH, 1990, INVEST OPHTH VIS SCI, V31, P2106
  • [7] FIDLER IJ, 1985, CANCER RES, V45, P4714
  • [8] GLEW SS, 1992, CANCER RES, V52, P4009
  • [9] CYTOTOXIC LYMPHOCYTES-T RECOGNIZE A FRAGMENT OF INFLUENZA-VIRUS MATRIX PROTEIN IN ASSOCIATION WITH HLA-A2
    GOTCH, F
    ROTHBARD, J
    HOWLAND, K
    TOWNSEND, A
    MCMICHAEL, A
    [J]. NATURE, 1987, 326 (6116) : 881 - 881
  • [10] HALLORAN PF, 1992, J IMMUNOL, V148, P3837